Qube Research & Technologies (QRT)
RCUS icon

Qube Research & Technologies (QRT)’s Arcus Biosciences RCUS Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$833K Buy
+38,556
New +$833K ﹤0.01% 2567
2025
Q3 		– Sell
-84,049
Closed -$684K – 3880
2025
Q2 		$684K Buy
+84,049
New +$718K ﹤0.01% 2600
2021
Q2 		– Sell
-23,433
Closed -$658K – 2715
2021
Q1 		$658K Buy
23,433
+12,726
+119% +$443K 0.01% 1025
2020
Q4 		$278K Sell
10,707
-421
-4% -$10.2K ﹤0.01% 1383
2020
Q3 		$191K Sell
11,128
-19,869
-64% -$444K ﹤0.01% 1407
2020
Q2 		$767K Buy
+30,997
New +$837K 0.01% 955

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Qube Research & Technologies (QRT)'s RCUS Position: Q1 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Arcus Biosciences (RCUS) in Q1 2026: 38,556 shares worth $833K. The stake represents ﹤0.01% of the portfolio and ranks #2567 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in RCUS as recently as Q2 2025.

Qube Research & Technologies (QRT) first reported a position in RCUS in Q2 2020 and has held it in 6 quarters since. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.

  • Qube Research & Technologies (QRT) held 38,556 shares of Arcus Biosciences worth $833K as of Q1 2026.
  • Arcus Biosciences was a new Qube Research & Technologies (QRT) position in Q1 2026.
  • Arcus Biosciences made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #2567 holding.
  • Qube Research & Technologies (QRT) first reported a position in Arcus Biosciences in Q2 2020 and has held it in 6 quarters since.
  • 210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.